Results
1 -
10 of
94Apsel et al..
Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases, Nature Chemical Biology, 2008 Verheijen J.C..
Phosphatidylinositol 3-kinase (PI3K) inhibitors as anticancer drugs, Drugs of the Future, 2007 Ma Xiao-Dong, Qiu Ni, Yang Bo, He Qiao-Jun, Hu Yong-Zhou.
Novel quinoline-derived mTOR inhibitors with remarkable enzymatic and cellular activities: design, synthesis and biological evaluation, Med. Chem. Commun., 2016 Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell lines, Cancer Chemotherapy and Pharmacology Non-Invasive Glutamine PET Reflects Pharmacological Inhibition of BRAFV600En In Vivo, Molecular Imaging and Biology Use of Patient-Derived Orthotopic Xenografts (PDOX) to Evaluate Transformative Cancer Therapeutics, Patient-Derived Mouse Models of Cancer Bergamini et al.
A selective inhibitor reveals PI3Kgamma dependence of TH17 cell differentiation.
Nature Chemical Biology, doi: 10.1038/nchembio.957, published online 29 April 2012
http://www.nature.com/naturechemicalbiology, Nature Chemical Biology